TC
Insider selling
Thomas Catinazzo sold $329K of Relay Therapeutics, Inc. (RLAY) stock
Thomas Catinazzo, Chief Financial Officer of Relay Therapeutics, Inc. (RLAY), sold 17,717 shares of RLAY stock worth $329K, per an SEC Form 4 filed Oct 8, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Oct 6, 2026, 2 days before it was made public.
RLAY has moved -4.2% since the trade date, from $18.74 to $17.95 (Oct 7, 2026 close).
- Traded
- Oct 6, 2026
- Disclosed
- Oct 8, 2026
- Filing delay
- 2 days
- Price since
- -4.2%
- Role
- Chief Financial Officer
- Source
- SEC Form 4
More RLAY insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.